– Reuters
Related Posts
Wedbush Reiterates Outperform on Amazon.com, Maintains $180 Price Target
Wedbush analyst Scott Devitt reiterates Amazon.com (NASDAQ:AMZN) with a Outperform and maintains $180 price target.
Maxim Group Initiates Coverage On Acrivon Therapeutics with Buy Rating, Announces Price Target of $24
Maxim Group analyst Michael Okunewitch initiates coverage on Acrivon Therapeutics (NASDAQ:ACRV) with a Buy rating and announces Price Target of…